Significance of thrombolysis in myocardial infarction (TIMI) grade 2 flow early after thrombolysis followed by immediate percutaneous coronary intervention in patients with acute myocardial infarction

Circulation Journal

Volumn 67, Issue 3, 2003, Pages 238-242

  Okuda, Jun ^a   Kimura, Kazuo ^a   Kosuge, Masami ^a   Endo, Tsutomu ^a   Sugano, Teruyasu ^a   Nakatogawa, Tomoyori ^a   Ishikawa, Toshiyuki ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Myocardial infarction; Reperfusion; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN; MONTEPLASE; SARPOGRELATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG FATALITY; ENZYME ANALYSIS; FEMALE; FIBRINOLYTIC THERAPY; FLOW KINETICS; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART REINFARCTION; HEART VENTRICLE WALL MOTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR PATENCY;

EID: 0037349818     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.238     Document Type: Article

References (23)

1. The TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase I findings. N Engl J Med 1985; 312: 923-936.
2. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
3. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-679.
4. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125-130.
5. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thorombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. J Am Coll Cardiol 1999; 34: 1954-1962.
6. Herrmann HC, Moliterno DJ, Ohman EM, Stebbins AL, Bode C, Betriu A, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction. J Am Coll Cardiol 2000; 36: 1489-1496.
7. Nagao K, Hayashi N, Kanmatsuse K, Kikuchi S, Ohuba T, Takahashi H. An early and complete reperfusion strategy for acute myocardial infarction using fibrinolysis and subsequent transluminal therapy: The FAST trial. Circ J 2002; 66: 576-582.
8. Kimura K, Tsukahara K, Usui T, Okuda J, Kitamura Y, Kosuge M, et al. Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals. Jpn Circ J 2001; 65: 901-906.
9. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: Analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104: 636-641.
10. Zijlstra F, Ernst N, de Boer MJ, Nibbering E, Suryapranata H, Hoorntje JC, et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol 2002; 39: 1733-1737.
11. Kawai C, Yui Y, Hosoda S, Nobuyoshi M, Suzuki S, Sato H, et al. A pospective, randomized, double-blind multicenter traial of single bolus injection of the novel modified t-PA E6010 in the treatment of acute myocardial infarction: Comparison with native t-PA. J Am Coll Cardiol 1997; 29; 1447-1453.
12. Nakamura K, Kariyazono H, Moriyama Y, Toyohira H, Kubo H, Yotsumoto G, et al. Effect of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin. Blood Coagul Fibrinolysis 1999; 10: 513-519.
13. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Assosiation Task Force on Practice Guidelines. J Am Coll Cardiol 1996; 28: 1328-1428.
14. de Lemos JA, Antman EM, Giugliano RP, McCabe CH, Murphy SA, Van de Werf F, et al. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Am J Cardiol 2000; 85: 299-304.
15. Sandler H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968; 75: 325-334.
16. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986; 74: 293-305.
17. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996; 334: 7-12.
18. Karagounis LA, Sorensen SG, Menlove RL, Moreno F, Anderson JL. Dose Thrombolysis in Myocardial Infarction (TIMI) perfusion grade 2 represent a mostly patient artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 Study. J Am Coll Cardiol 1992; 19: 1-10.
19. Reiner JS, Lundergan CF, Fung A, Coyne K, Cho S, Israel N, et al. Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. Circulation 1996; 94: 2441-2446.
20. Akasaka T, Yoshida K, Kawamoto T, Kaji S, Ueda Y, Yamamuro A, et al. Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation 2000; 101: 2361-2367.
21. Zahger D, Karagounis LA, Cercek B, Anderson JL, Sorensen S, Moreno F, et al. Incomplete recanalization as an impoetant determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolitic therapy for acute myocardial infarction. Am J Cardiol 1995; 76: 749-752.
22. Schweiger MJ, Cannon CP, Murphy SA, Gibson CM, Cook JR, Giugliano RP, et al. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (The combined TIMI 10B-TIMI14 experience). Am J Cardiol 2001; 88: 831-836.
23. Brener SJ, Zeymer U, Adgey J, Vrobel TR, Ellis SG, Neuhaus KL, et al. Epitifibatide and low-dose tissue plasminogen activator in acute myocardial infarction. J Am Coll Cardiol 2002; 39: 377-386.